Royalty Pharma
RPRX
#1190
Rank
A$23.71 B
Marketcap
$40.25
Share price
0.81%
Change (1 day)
-1.89%
Change (1 year)

Earnings for Royalty Pharma (RPRX)

Earnings in 2024 (TTM): A$1.80 Billion

According to Royalty Pharma's latest financial reports the company's current earnings are A$2.23 Billion. In 2023 the company made an earning of A$2.89 Billion, an increase over its 2022 earnings that were of A$0.64 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Royalty Pharma from 2019 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) A$1.80 B-37.56%
2023 A$2.89 B351.47%
2022 A$0.64 B-70.3%
2021 A$2.16 B-24.3%
2020 A$2.85 B-31.9%
2019 A$4.19 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$54.5 M-97.08%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.40 B 457.26%๐Ÿ‡บ๐Ÿ‡ธ USA
A$15.58 B 734.54%๐Ÿ‡บ๐Ÿ‡ธ USA